Alembic Pharmaceuticals gets USFDA approval for Dapsone Gel, 5% EP News Bureau Jun 29, 2026 Dapsone Gel is indicated for the topical treatment of acne vulgaris
Alembic Pharma received eight USFDA approvals in Q3FY24 EP News Bureau Jan 2, 2024 The company has received five final approvals and three tentative approvals
